The Oncology Institute Stock Alpha and Beta Analysis
| TOIIW Stock | USD 0.02 0 25.13% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as The Oncology Institute. It also helps investors analyze the systematic and unsystematic risks associated with investing in Oncology Institute over a specified time horizon. Remember, high Oncology Institute's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Oncology Institute's market risk premium analysis include:
Beta 0.26 | Alpha 2.66 | Risk 22.23 | Sharpe Ratio 0.17 | Expected Return 3.8 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Oncology |
Oncology Institute Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Oncology Institute market risk premium is the additional return an investor will receive from holding Oncology Institute long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oncology Institute. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Oncology Institute's performance over market.| α | 2.66 | β | 0.26 |
Oncology Institute expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Oncology Institute's Buy-and-hold return. Our buy-and-hold chart shows how Oncology Institute performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Oncology Institute Market Price Analysis
Market price analysis indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By understating and applying Oncology Institute stock market price indicators, traders can identify Oncology Institute position entry and exit signals to maximize returns.
Oncology Institute Return and Market Media
The median price of Oncology Institute for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 0.0208 with a coefficient of variation of 48.4. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.02, and mean deviation of 0.01. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Oncology Institute faces potential Nasdaq delisting - Investing.com | 12/20/2024 |
2 | Why The Oncology Institute Is Skyrocketing So Far In 2025 - Insider Monkey | 02/03/2025 |
3 | Acquisition by Miller Matthew P of 73684 shares of Oncology Institute at 0.95 subject to Rule 16b-3 | 02/07/2025 |
4 | Acquisition by Kaushal Mohit of 22708 shares of Oncology Institute subject to Rule 16b-3 | 02/21/2025 |
5 | Wafa Samara, PharmD, Shares How Oncology Pharmacists Are Transforming Cancer Care at City of Hope - Pharmacy Times | 03/10/2025 |
About Oncology Institute Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Oncology or other stocks. Alpha measures the amount that position in The Oncology Institute has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.0265 | 0.0235 | Price To Sales Ratio | 0.53 | 0.51 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oncology Institute in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oncology Institute's short interest history, or implied volatility extrapolated from Oncology Institute options trading.
Build Portfolio with Oncology Institute
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.